Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases
Authors:
Top Cited Papers
- 31 August 2024
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (3) , 427-437
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Physiological Systems in Promoting Frailty2022
- Association of shorter leucocyte telomere length with risk of frailtyJournal of Cachexia, Sarcopenia and Muscle, 2022
- Frailty is associated with increased risk of cirrhosis disease progression and deathHepatology, 2021
- Determination of Biological Age: Geriatric Assessment vs Biological BiomarkersCurrent Oncology Reports, 2021
- Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus StatementHepatology, 2021
- Modulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseHepatology, 2018
- Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver DiseaseLiver Transplantation, 2018
- Body Composition Profiling in the UK Biobank Imaging StudyObesity, 2018
- Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisHepatology, 2017
- Development of a novel frailty index to predict mortality in patients with end‐stage liver diseaseHepatology, 2017